G0 Glycan (GN1 type)(61687-27-2)
- Name: G0 Glycan (GN1 type)
- Synonyms:G0 Glycan (GN1 type);D-Glucose, O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-(1→3)-O-[O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-O-β-D-mannopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-
- Molecular Formula:C42H71N3O31
- Molecular Weight:1114.02
- CAS Registry Number:61687-27-2
- EINECS:
- Melting Point:1529.1±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 616214-89-2/Naphtho[2,1-b]furan-1-acetamide, N-(phenylmethyl)-
- 616216-96-7/(2E)-3-(2-Iodophenyl)-1-(4-methylpiperazin-1-yl)prop-2-en-1-one
- 616224-66-9/2H-3,1-Benzoxazine-2,4(1H)-dione, 6-fluoro-5-methyl-
- 616227-75-9/Brexpiprazole Impurity 19
- 616234-50-5/Methyl 2,4-Di-O-acetyl-3-deoxy-3-fluoro-b-D-xylopyranoside
- 6162-47-6/2,5-dimethylpiperidin-4-ol hydrochloride
- 6162-66-9/Dodecanamide, N-(2-mercaptoethyl)-
- 61626-80-0/Spiro[2H-1,3-benzoxazine-2,2'-tricyclo[3.3.1.13,7]decane], 3,4-dihydro-8-iodo-6-(1-methylethyl)-
- 61626-81-1/Spiro[2H-1,3-benzoxazine-2,2'-tricyclo[3.3.1.13,7]decane], 3,4-dihydro-8-iodo-6-tricyclo[3.3.1.13,7]dec-1-yl-
- 61626-82-2/Spiro[2H-1,3-benzoxazine-2,2'-tricyclo[3.3.1.13,7]decane], 5,7-dichloro-3,4-dihydro-6,8-dimethyl-
- 61626-83-3/Spiro[2H-1,3-benzoxazine-2,1'-cyclohexane], 6-(1,1-dimethylethyl)-3,4-dihydro-8-iodo-
- 61626-84-4/Spiro[2H-pyrido[3,2-h]-1,3-benzoxazine-2,2'-tricyclo[3.3.1.13,7]decane], 6-chloro-3,4-dihydro-
- 61626-93-5/Phenol, 2-(aminomethyl)-4-tricyclo[3.3.1.13,7]dec-1-yl-, hydrochloride (1:1)
- 61631-11-6/2-Propenoic acid, butyl ester, polymer with 3-buten-2-ol
- 61633-73-6/Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16-methyl-21-(1-oxobutoxy)-, (6α,11β,16α)-
- 61666-40-8/Borate(1-), trihydro(2,2,2-trifluoroacetato-κO)-, sodium (1:1), (T-4)-
- 616827-13-5/3-Pyrrolidinone, 4-(aminomethyl)-, (3Z)-, (O-methyloxime), 2,2,2-trifluoroacetate (1:2)
- 616865-28-2/Chlorzoxazone 13C1
- 616871-83-1/1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one trifluoroacetate salt hydrate
- 61687-27-2/G0 Glycan (GN1 type)
- 616875-85-5/2-amino-1-methylimidazol-4-ol
- 616875-89-9/Tert-Butyl 3-(2-Cyanoethyl)-4-Oxopiperidine-1-Carboxylate
- 616875-91-3/Trans-Octahydro-[1,6]Naphthyridine-6-Carboxylic Acid Tert-Butyl-Ester(WX110198)
- 616884-66-3/OMDM-5
- 616884-67-4/OMDM-6
- 616889-42-0/Propanoic acid, 3-(4-hydroxyphenoxy)-, 2,5-dioxo-1-pyrrolidinyl ester
- 616890-33-6/Cis-Tert-Butyl 2-Allyl-3-Hydroxypiperidine-1-Carboxylate
- 616898-66-9/1H-Indole-3-acetic acid, 1-[1-[(1,1-dimethylethoxy)carbonyl]-4-piperidinyl]-α-oxo-, methyl ester
- 61692-67-9/Benzenebutanoic acid, γ-oxo-4-[2-[(2,2,2-trifluoroacetyl)amino]propyl]-
- 61694-42-6/Benzamide, N-[2-[[(4-chlorophenyl)methyl]ethylamino]ethyl]-5-(ethylsulfonyl)-2-methoxy-, hydrochloride (1:1)